For example, adenomatous polyposis coli (APC) promoter methylation could be a biomarker for early diagnosis of prostate cancer [8], and O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation might be a predictive biomarker for cancer prognosis [9]. This evidence concerns the gene APC and prostate carcinoma.